The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer

被引:0
作者
Meghan Brennan
Paul Gass
Lothar Häberle
Daidong Wang
Arndt Hartmann
Michael P. Lux
Matthias W. Beckmann
Michael Untch
Peter A. Fasching
机构
[1] University of California at Los Angeles,Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine
[2] University Hospital Erlangen,Department of Gynecology and Obstetrics
[3] Comprehensive Cancer Center Erlangen-EMN,Biostatistics Unit, Department of Gynecology and Obstetrics
[4] Friedrich-Alexander-University Erlangen-EMN,School of Public Heath, Biostatistics Department
[5] University Hospital Erlangen,Institute of Pathology
[6] University of California at Los Angeles,Department of Obstetrics and Gynecology
[7] University Hospital Erlangen,undefined
[8] Comprehensive Cancer Center Erlangen-EMN,undefined
[9] Friedrich- Alexander-University Erlangen-EMN,undefined
[10] Helios Klinikum Berlin-Buch,undefined
来源
Breast Cancer Research and Treatment | 2018年 / 171卷
关键词
Breast cancer; Neoadjuvant therapy; Clinical trial participation; pCR; Mastectomy; Trial participation outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:747 / 758
页数:11
相关论文
共 641 条
  • [1] Shahar T(2012)The impact of enrollment in clinical trials on survival of patients with glioblastoma J Clin Neurosci 19 1530-1534
  • [2] Nossek E(1985)Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials Cancer 56 1710-1718
  • [3] Steinberg DM(2001)Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect” J Clin Epidemiol 54 217-224
  • [4] Rozovski U(2005)Systematic review to determine whether participation in a trial influences outcome BMJ 330 1175-780
  • [5] Blumenthal DT(2007)Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate Cochrane Database Syst Rev:MR000009 106 dju002-1348
  • [6] Bokstein F(2014)Comparison of survival outcomes among cancer patients treated in and out of clinical trials J Natl Cancer Inst 216 774-563
  • [7] Sitt R(2013)Does enrollment in cancer trials improve survival? J Am Coll Surg 104 1343-866
  • [8] Freedman S(2005)Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer Cancer 49 553-1545
  • [9] Corn BW(2013)Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients Eur J Cancer 33 862-2493
  • [10] Kanner AA(1997)Clinical and pathological response to primary chemotherapy in operable breast cancer Eur J Cancer 82 1539-234